LCDR Amy Ramanadham, Pharm.D., M.S., serves as CDER’s Acting Associate Director for Drug Safety Operations. She is responsible for the management of significant and timely drug safety issues, as well as the creation and oversight of CDER processes for management of complex safety issues.
LCDR Ramanadham joined CDER in 2012 in the Drug Safety Operations program. She led multiple drug safety projects, including the development of the REMS@FDA website and the Newly Identified Safety Signals initiative process and LiST tracker, which strengthened CDER’s drug safety knowledge management capabilities.
LCDR Ramanadham received her doctoral degree in pharmacy from the University of Maryland, School of Pharmacy, and a master’s degree in pharmacoepidemiology at the University of Florida, College of Pharmacy.